Concepedia

Xiang Ling

XL

Statistics

Publications

57

Citations

4.1K

H-Index

34

Active since

2004

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Shenzhen University

China Pharmaceutical University

Harvard University

Brigham and Women's Hospital

Xiang Ling is an author at Roswell Park Comprehensive Cancer Center specializing in pharmacology, oncology, and medicine.

Publications per year

2004–2022

57

Publications

57

Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes <i>p53</i> -deficient cancers to mTOR inhibition

Na Kong, Wei Tao, Xiang Ling et al. · Science Translational Medicine · 2019 · 306 citations · Full text

Pharmacy, Oncology, Pharmacology +17

B, N Codoped and Defect‐Rich Nanocarbon Material as a Metal‐Free Bifunctional Electrocatalyst for Oxygen Reduction and Evolution Reactions

Tao Sun, Jun Wang, Chuntian Qiu et al. · Advanced Science · 2018 · 280 citations · Full text

Natural Sciences, Chemistry, Materials Science +17

Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy

Xiang Ling, Jiasheng Tu, Junqing Wang et al. · ACS Nano · 2018 · 262 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Engineering the Electronic Structure of MoS<sub>2</sub> Nanorods by N and Mn Dopants for Ultra-Efficient Hydrogen Production

Tao Sun, Jun Wang, Xiao Chi et al. · ACS Catalysis · 2018 · 245 citations

Natural Sciences, Chemistry, Materials Science +17

Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Fengzhi Li, Tao Jiang, Qingyong Li et al. · PubMed · 2017 · 226 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 57